Who is eligible for clinical trial NCT06590285?

Participants must meet the protocol's inclusion criteria for GVHD. The stated age range is 18 Years. Confirm all requirements with the study coordinator.

Does clinical trial NCT06590285 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-04-03

Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation (NCT06590285)

Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation (DREAM-BMT)

🟢 Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program Sponsor: Scripps Health

🩺 Plain-English Summary (8th-Grade Level)

This randomized, phase I/II, open-label study will investigate the efficacy and safety of an educational sleep intervention vs standard of care in adults undergoing alloHSCT. The randomization target in this pilot phase is 60 patients.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (2 items).

Location: Scripps Health — San Diego, California

Age range: 18 Years

🧪 Interventions in This Study

App-based Educational Intervention (BEHAVIORAL)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Male or female patients aged 18 or older at the time of study informed consent.
Have plan to undergo alloHSCT from any donor source using bone marrow, peripheral blood stem cells, or cord blood. Recipients of non-myeloablative, myeloablative and reduced intensity conditioning are eligible.
Patients have access to digital device capable of downloading study app
Patients able to read study documents and able to complete informed consent within the study app

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Failed prior alloHSCT within the past 6 months

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

Scripps Health — San Diego, California

📞 Contact the Study Coordinator

Phone: (858) 784-2701

Email: new.jacob@scrippshealth.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in GVHD

Vorinostat for Graft-versus-host Disease (GVHD) Prevention in Non-Malignant Adolescent and Young Adults (AYA) Population — Ann Arbor, Michigan
TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT — Palo Alto, California

Explore by condition: All GVHD clinical trials

💡 How to Participate

Check the checklist above to see if you may qualify.
Contact the study coordinator using the phone/email above.
Ask about the visit schedule, what is covered at no cost, and any travel support.
Confirm with your own doctor before making a decision.

🏛️ View Official NIH Record ↗